- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Soligenix Inc (SNGX)Soligenix Inc stock price live, this page displays NASDAQ SNGX stock exchange data. View the SNGX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Soligenix Inc real time stock price chart below.
What Is the Soligenix Inc Stock Price Today?
The Soligenix Inc stock price today is 3.2300.
What Is the Stock Symbol for Soligenix Inc?
The stock symbol for Soligenix Inc is "SNGX."
What Stock Exchange Does Soligenix Inc Trade On?
Soligenix Inc is listed and trades on the NASDAQ stock exchange.
Is Soligenix Inc a Good Stock to Buy?
Determining whether Soligenix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNGX quote. (ISIN: US8342236044)
What Is the Soligenix Inc Stock Price Today?
The Soligenix Inc stock price today is 3.2300.
What Is the Stock Symbol for Soligenix Inc?
The stock symbol for Soligenix Inc is "SNGX."
What Stock Exchange Does Soligenix Inc Trade On?
Soligenix Inc is listed and trades on the NASDAQ stock exchange.
Is Soligenix Inc a Good Stock to Buy?
Determining whether Soligenix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNGX quote. (ISIN: US8342236044)
NASDAQ
Currency in USD
3.2300
-0.0900(-2.71%)
Closed
After Hours
3.2100-0.0200(-0.62%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.2200
3.3100
52 wk Range
1.8301
19.2000
SNGX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.22003.3100
52 wk Range
1.830119.2000
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockSNGX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
22.5000
Upside
+596.5944%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Soligenix Inc Company Profile
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX302, an IDR technology which is in Phase IIa study to treat mil-to-moderate Psoriasis; and SGX945 and IDR technology that is in Phase IIa protocol for the treatment of Aphthous Ulcers in Behçet’s Disease. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia, Ib, and Ic clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
Compare SNGX to Peers and Sector
Metrics to compare | SNGX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNGXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −2.8x | −0.7x | |
PEG Ratio | −0.02 | 0.06 | 0.00 | |
Price/Book | 1.4x | 2.9x | 2.6x | |
Price / LTM Sales | 22.3x | 25.1x | 3.2x | |
Upside (Analyst Target) | - | 296.5% | 46.4% | |
Fair Value Upside | Unlock | 8.3% | 6.9% | Unlock |
Analysts' Recommendations
1 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 22.5000
(+596.59% Upside)
People Also Watch
FAQ
What Is the Soligenix Inc (SNGX) Stock Price Today?
The Soligenix Inc stock price today is 3.23
What Stock Exchange Does Soligenix Inc Trade On?
Soligenix Inc is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Soligenix Inc?
The stock symbol for Soligenix Inc is "SNGX."
What Is the Soligenix Inc Market Cap?
As of today, Soligenix Inc market cap is 8.11M.
What is Soligenix Inc Earnings Per Share?
The Soligenix Inc EPS is -5.94.
From a Technical Analysis Perspective, Is SNGX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.